1997
DOI: 10.1159/000154852
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Human Natural Killer Cell Function in vitro by Glucose Concentrations Seen in Poorly Controlled Diabetes

Abstract: Type 1 and type 2 diabetes mellitus are associated with an increased risk of viral infections and certain tumors. Natural killer (NK) cells appear to have a central role in the immune defense against viral infection as well as tumor cells, and impairment of NK function could result in an increased incidence of infection or tumors. We show that exposure of NK cells to elevated glucose concentrations (in the range seen in poorly controlled diabetes) results in a significant inhibition of their cytolytic function… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 16 publications
2
8
0
Order By: Relevance
“…The ability of NK cells to lyse tumor cells was measured using a 51 Cr release assay (Whalen et al, 1999;Whalen, 1997). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human chronic myelogenous leukemia) cell line.…”
Section: Cytotoxicity Assaymentioning
confidence: 99%
“…The ability of NK cells to lyse tumor cells was measured using a 51 Cr release assay (Whalen et al, 1999;Whalen, 1997). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human chronic myelogenous leukemia) cell line.…”
Section: Cytotoxicity Assaymentioning
confidence: 99%
“…NK cytotoxicity was measured using a 51 Cr release assay (Whalen et al, 1997(Whalen et al, , 1999. The target cells in all cytotoxicity assays were cells of the NK-susceptible K562 (human chronic myelogenous leukemia) cell line.…”
Section: Chromium Release Assaymentioning
confidence: 99%
“…NK cytotoxicity was measured using a 51 Cr release assay (Whalen, 1997;Whalen et al, 1999). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human chronic myelogenous leukemia) cell line.…”
Section: Chromium Release Assaymentioning
confidence: 99%